TNF and rheumatoid arthritis: An increased activation of circulating monocytes has been reported in patients receiving anti-TNF therapy [26] and the elevations of monocyte subpopulation can be seen in RA patients with coronary artery atherosclerosis and are associated with an increased CVD risk [28, 29].